Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
67.51
-2.27 (-3.25%)
At close: Apr 28, 2026, 4:00 PM EDT
67.51
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Solventum Revenue
In the year 2025, Solventum had annual revenue of $8.33B with 0.86% growth. Solventum had revenue of $2.00B in the quarter ending December 31, 2025, a decrease of -3.71%.
Revenue (ttm)
$8.33B
Revenue Growth
+0.86%
P/S Ratio
1.41
Revenue / Employee
$404,440
Employees
20,584
Market Cap
11.71B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.24B |
| Avantor | 6.55B |
| ResMed | 5.40B |
| Bausch + Lomb | 5.10B |
| The Cooper Companies | 4.15B |
| Align Technology | 4.03B |
| AptarGroup | 3.78B |
| West Pharmaceutical Services | 3.22B |
SOLV News
- 14 days ago - Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026 - PRNewsWire
- 5 weeks ago - Solventum Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 6 weeks ago - Solventum to Participate in the 2026 KeyBanc Healthcare Forum - PRNewsWire
- 2 months ago - Solventum beats quarterly estimates on strong demand for surgical products - Reuters
- 2 months ago - Solventum Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance - PRNewsWire
- 3 months ago - Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 - PRNewsWire
- 4 months ago - Solventum Completes Acquisition of Acera Surgical - PRNewsWire